Hochschulschrift
OV-MZ-6 ovarian cancer cells overexpressing kallikrein-related peptidases KLK4, 5, 6 and 7: effects on expression of cancer-related genes
- Alternative title
-
Überexpression der Kallikrein-ähnlichen Peptidasen KLK4, 5, 6 und 7 in OV-MZ-6 Ovarialkarzinomzellen: Auswirkungen auf die Expression anderer krebsrelevanter Gene
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Technische Universität München, Dissertation, 2016
- Keyword
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der TU München
- (when)
-
2016
- Creator
-
Wang, Ping
- Contributor
-
Magdolen, Viktor
Kiechle, Marion B.
- URN
-
urn:nbn:de:bvb:91-diss-20160920-1296118-1-0
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:57 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Wang, Ping
- Magdolen, Viktor
- Kiechle, Marion B.
- Universitätsbibliothek der TU München
Time of origin
- 2016
Other Objects (12)
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
Kallikrein-related peptidase 10: a novel independent prognostic marker in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Ovarian cancer
Ovarian cancer
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer
Assessment of kallikrein-related peptidases 4, 5, 7 and 12 as prognostic biomarkers in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Cancer-related fatigue intervention
Cancer-related fatigue intervention
Ovarian cancer proteomics
Clinical relevance of kallikrein-related peptidases in advanced high-grade serous ovarian (KLK11, KLK15) and in triple-negative breast cancer (KLK11)
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
Kallikrein-related peptidase 10: a novel independent prognostic marker in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Ovarian cancer
Ovarian cancer
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer
Assessment of kallikrein-related peptidases 4, 5, 7 and 12 as prognostic biomarkers in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Cancer-related fatigue intervention
Cancer-related fatigue intervention
Ovarian cancer proteomics
Clinical relevance of kallikrein-related peptidases in advanced high-grade serous ovarian (KLK11, KLK15) and in triple-negative breast cancer (KLK11)
Kallikrein-related peptidases, Vol. 2.. Novel cancer-related biomarkers
Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer
Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer
Kallikrein-related peptidase 10: a novel independent prognostic marker in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Ovarian cancer
Ovarian cancer
Assessment of kallikrein-related peptidases 4 and 6 (KLK4 and KLK6) as candidate biomarkers in prostate and ovarian cancer
Assessment of kallikrein-related peptidases 4, 5, 7 and 12 as prognostic biomarkers in advanced high-grade serous ovarian cancer and triple-negative breast cancer
Cancer-related fatigue intervention
Cancer-related fatigue intervention
Ovarian cancer proteomics